基于AGREE Ⅱ对成人抑郁症临床实践指南质量评价研究

Abstract
Figure/Table
References (24)
Related Citation (15)

Download: PDF (727 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To evaluate the quality of clinical practice guidelines for depression with adults, and to provide reference for the formulation or update of adult depression guidelines in the future. Methods The document database and guide database were searched by computer, and the retrieval time was from January 1, 2015 to January 31, 2020, The application of clinical guideline research and evaluation system (AGREE Ⅱ) to evaluate the quality of guidelines. Results A total of four English guidelines were included, all of which were evidence-based guidelines, the included guidelines scored low in the fields of “participants” “application” and “conscientiousness”, with the scores being 57.9%, 66.0% and 66.7%, respectively; they scored higher in the areas of “scope and purpose” “clarity” and “independence”, at 75.5%, 79.2%, and 79.2%, respectively. The overall quality of the four guides is high, two Grade A recommendations, two Grade B recommendations. Conclusion The overall quality of the inclusion guidelines is high, however, the quality in the field of “participants” “application” and “conscientiousness” are relatively low, so we should better improve the content of adult depression guidelines in the future.

Key words： Depression Clinical practice guideline Adults Clinical guideline research and evaluation system

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	MA Huaping1 HAN Zhenyun2 HU Wenyue1 LIN Jingfeng1 LIU Ganlu1 WANG Zhenyi1

Cite this article:

MA Huaping1 HAN Zhenyun2 HU Wenyue1 LIN Jingfeng1 LIU Ganlu1 WANG Zhenyi1. Based on AGREE Ⅱ depression clinical practice guidelines for the adult population quality evaluation research[J]. 中国医药导报, 2020, 17(32): 9-12.

URL:

http://www.yiyaodaobao.com.cn/EN/ OR http://www.yiyaodaobao.com.cn/EN/Y2020/V17/I32/9

[1] 姚树桥，杨彦春.医学心理学[M].北京：人民卫生出版社，2013：141.
[2] World Health Organization WHO （2017）. Depression and Other Common Mental Disorders，Global Health Estimates[DB/OL].http：//apps.who.int/iris/bitstream/10665/254610/1/WHO-MSD-MER-2017.2-eng.pdf.
[3] Ng M，Fleming T，Robinson M，et al. Global，regional，and national prevalence of overweight and obesity in children and adults during 1980-2013：a systematic analysis for the Global Burden of Disease Study 2013 [J]. Lancet，2014（9945）：766-781.
[4] 王行环.循证临床实践指南的研发与评价[M].北京：中国协和医科大学出版社，2016：1.
[5] 张伶俐，李幼平，张川，等.中国儿童临床指南现状分析及循证临床指南评价[J].中国循证医学杂志，2011，11（9）：991-999.
[6] 丁翔宇，张古英，王伟秀，等.儿童中耳炎循证指南AGREEⅡ质量评价情况[J].中国医药导报，2019，16（30）：114-117.
[7] Brouwers MC，Lavis JN，Spithoff K. Appraisal of Guidelines for Research & Evaluation Ⅱ [S/OL]. 2013：1-59. http：//www.agreetrust.org.
[8] 陈尹，胡世莲，李幼平，等.全球药物干预治疗单纯性高血压指南的系统评价[J].中国循证医学杂志，2012（10）：1180-1194.
[9] 丁翔宇，王建欣，张古英，等.儿童青少年糖尿病临床循证指南质量AGREEⅡ评价情况[J].中国医药导报，2019， 16（27）：65-68.
[10] Shieh G. Choosing the best index for the average score intraclass correlation coefficient [J]. Behav Res Meth，2016，48（3）：994-1003.
[11] Qaseem A，Barry MJ，Kansagara D，et al. Clinical Guidelines Committee of the American College of Physicians. Nonpharmacologic Versus Pharmacologic Treatment of Adult Patients With Major Depressive Disorder：A Clinical Practice Guideline From the American College of Physicians [J]. Ann Intern Med，2016，164（5）：350-359.
[12] Canadian Network for Mood and Anxiety Treatments （CANMAT） 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder[S/OL]. 2016.https：//www.canmat.org/2019/03/17/2016-depression-guidelines/.
[13] Registered Nurses/Association of Ontario. Assessment and Interventions for Perinatal Depression Second Edition [S/OL].2018.https：//rnao.ca/sites/rnao-ca/files/bpg/Perinatal_Depression_FINAL_web_0.pdf.
[14] Malaysian Health Technology Assessment Section. CPG management of major depressive disorder（Second Edition）[S/OL]. 2019. http：//guide.medlive.cn/guideline/19788.
[15] 黄坡，郭玉红，李博，等.基于AGREEⅡ工具对国内外急性缺血性脑卒中临床实践指南的评价[J].中华中医药杂志，2020，35（1）：385-388.
[16] 林茂，曾力楠，李佳莲，等.全球指南临床适用性评价工具现状的系统评价[J].中国循证医学杂志，2020，20（4）：437-443.
[17] 靳英辉，张林，黄笛，等.临床实践指南制订方法——指南制订参与人员及组成分配[J].中国循证心血管医学杂志，2018，10（4）：385-391.
[18] 王明辉，张菁，曾宪涛，等.临床实践指南制订方法——患者的价值观和意愿[J].中国循证心血管医学杂志，2018， 10（10）：1153-1156.
[19] 王宇，饶友义，郭军，等，AGREEⅡ系统对现行国内外急性胰腺炎指南的评价分析[J].临床肝胆病杂志，2018，34（6）：1225-1230.
[20] 黄笛，黄瑞秀，郭晨煜，等.临床实践指南制订方法——证据分级与推荐强度[J].中国循证心血管医学杂志，2018，10（7）：769-776.
[21] 靳英辉，韩斐，王明辉，等.临床实践指南制订方法——证据向推荐意见转化[J].中国循证心血管医学杂志，2018，10（9）：1031-1038.
[22] 靳英辉，邓通，曾宪涛，等.临床实践指南制订方法——指南的实施与转化[J].中国循证心血管医学杂志，2019， 11（9）：1040-1042，1046.
[23] 靳英辉，黄瑞秀，靳永萍，等.临床实践指南制订方法——指南推荐意见的撰写及呈现[J].中国循证心血管医学杂志，2018，10（8）：897-902.
[24] 白雪，刘建平，郭宇博，等.建立中医药临床实践指南评价体系的思考[J].中国中药杂志，2020，45（7）：1596-1599.